Featured Articles

  1. Complex Parenteral Drug Manufacturing — A Foundation For Success 6/11/2020

    A first-hand account of what it takes to develop and manufacture complex parenteral drugs.

  2. Applying The Four Dimensions Of Sustainability To Create Capacity That Delivers Results Faster

    There are no shortcuts to growing capacity that delivers results faster and maintaining it is difficult. The key ingredient in growing enterprise value is sustainability. Learn how by applying the principle of sustainability using its four dimensions, finite resources are more wisely used with extraordinary results, lead time from concept to commercialization is greatly improved, and patients receive better medications faster.

  3. The Value Of Orphan Drug Designation

    More than 90% of rare diseases still have no FDA-approved treatment, even though rare diseases affect more than 25 million Americans. Despite the opportunities in the orphan drug market, there are challenges that may act as barriers to entry.

  4. 5 Key Factors For A Successful Tech Transfer

    Each tech transfer comes with a unique set of complex processes that need to be understood. While it includes the transfer of analytical methods and manufacturing processes, there is also a human dimension to consider.

  5. Supply Chain Transformation, 503B And Reducing Drug Shortages 9/11/2020

    Currently there are two great forces at work that are disrupting traditional models for advancing drug therapies from discovery to commercial production and distribution. This transformation, when complete, will impact the biopharmaceutical supply chain significantly and potentially achieve outcomes that were considered impossible a short time ago.

  6. Snapshot Of The Parenteral Drug Delivery Market 6/17/2022

    Growth in the development of parenteral drugs is driving demand for advanced drug delivery devices such as prefilled syringes, autoinjectors, and pen-injectors, growing segments in fill-finish manufacturing.

  7. How A CDMO Achieves Finished Product Lyophilization With Limited And Expensive API 6/27/2022

    Agile, cost-effective lyophilization services can accelerate the development of complex drug candidates that present stability challenges, but lyophilization can be challenging, expensive, and time-consuming.

  8. Innovating During The COVID-19 Pandemic

    Pharmaceutics International, Inc., (Pii) is a premier CDMO, offering unparalleled scientific insight and depth of product knowledge, while supplying high-quality dosage forms that enhance the lives of patients worldwide. Pii provides customized and flexible solutions across several dosage forms and has experience with a broad range of compounds.

  9. Meet The Scientist — Sundeep Sethia, Ph.D.

    Many promising drug development candidates never advance beyond the preclinical stage because of bioavailability and solubility challenges. Dr. Sundeep Sethia has dedicated his life toward overcoming this initial hurdle in the drug development process.

  10. Scaling Aseptic Pharmaceutical Production During Uncertainty

    Aseptic production and fill/finish operations are complex, and unexpected challenges should not disrupt the outcome of delivering needed pharmaceutical products to patients.